Literature DB >> 1731430

Autologous blood donation: hemodynamics in a high-risk patient population.

B D Spiess1, R Sassetti, R J McCarthy, R F Narbone, K J Tuman, A D Ivankovich.   

Abstract

Transfusion practices have changed dramatically in recent years as a result of the acquired immune deficiency syndrome crisis. The use of preoperative donation of autologous blood units has gained popularity. Healthy individuals tolerate phlebotomy well, experiencing a 2- to 5-percent incidence of vasovagal reactions. However, no systematic study of hemodynamic function during phlebotomy exists for patients who have major cardiovascular or multiple organ disease (high-risk patients). The following protocol examines blood pressure, heart rate, cardiac output, lead II electrocardiogram, and pulse oximetry in 123 patients donating a total of 224 units of blood in a new high-risk autologous blood donation program that was conducted in a postanesthesia care unit over the past 18 months. Changes in hemodynamic variables during phlebotomy were consistent with mild volume depletion; the changes did not result in overall differences in the courses of the groups. Significant numbers of patients exhibited systolic or diastolic hypotension, dysrhythmias, syncope, and tachycardia. Because tolerance for hypotension (vasovagal reactions) is decreased in patients with coronary artery disease, appropriate monitoring may be warranted to maximize the safety of elective phlebotomy. Further study is required to stratify risks and to determine which hemodynamic variables are predictive of adverse events.

Entities:  

Mesh:

Year:  1992        PMID: 1731430     DOI: 10.1046/j.1537-2995.1992.32192116425.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  Autologous blood transfusion therapy.

Authors:  S H Jackson
Journal:  West J Med       Date:  1992-11

2.  Cardiac surgical patients must not be denied the benefits of autologous blood predonation.

Authors:  J F Hardy; S Bélisle; F Décary
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

3.  Debate: transfusing to normal haemoglobin levels will not improve outcome.

Authors:  G Alvarez; P C Hébert; S Szick
Journal:  Crit Care       Date:  2001-03-08       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.